Publications by authors named "Julie McElrath"

Claim this Profile
B
Building an integrated care continuum for youth substance use treatment and recovery: A qualitative study.
Kasey R Claborn, Katie A McCormick, Jake Samora, Julie McElrath, Lori K Holleran Steiker

J Soc Work Pract Addict· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants.
Nicole Espy, Xue Han, Shannon Grant, Esther Kwara, Bharathi Lakshminarayanan, Julie McElrath

PLOS Glob Public Health· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency.
Miranda C Lahman, Thomas M Schmitt, Kelly G Paulson, Nathalie Vigneron, Denise Buenrostro, Julie M McElrath

Sci Transl Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials.
Stephanie Fischinger, Deniz Cizmeci, Davy Deng, Shannon P Grant, Nicole Frahm, Julie McElrath

PLoS Pathog· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency.
Germán Gustavo Gornalusse, Lucia N Vojtech, Claire N Levy, Sean M Hughes, Yeseul Kim, Julie McElrath

Viruses· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine.
Jue Hou, Shuhui Wang, Manxue Jia, Dan Li, Ying Liu, Julie McElrath

J Immunol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials.
Yunda Huang, Lily Zhang, Holly Janes, Nicole Frahm, Abby Isaacs, M Julie McElrath

Vaccine· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials.
Peter B Gilbert, Michal Juraska, Allan C deCamp, Shelly Karuna, Srilatha Edupuganti, Julie McElrath

Stat Commun Infect Dis· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of HIV vaccine candidates for concurrent testing in an efficacy trial.
Ying Huang, Carlos DiazGranados, Holly Janes, Yunda Huang, Allan C deCamp, Julie McElrath

Curr Opin Virol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and visualization of multidimensional antigen-specific T-cell populations in polychromatic cytometry data.
Lin Lin, Jacob Frelinger, Wenxin Jiang, Greg Finak, Chetan Seshadri, Julie McElrath

Cytometry A· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study.
Glenda E Gray, Zoe Moodie, Barbara Metch, Peter B Gilbert, Linda-Gail Bekker, M Julie McElrath

Lancet Infect Dis· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 Gag co-opts a cellular complex containing DDX6, a helicase that facilitates capsid assembly.
Jonathan C Reed, Britta Molter, Clair D Geary, John McNevin, Julie McElrath

J Cell Biol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.
Glenda E Gray, Mary Allen, Zoe Moodie, Gavin Churchyard, Linda-Gail Bekker, M Julie McElrath

Lancet Infect Dis· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection.
Jie Yu, Huiyuan Chen, Helen Horton, Anju Bansal, Julie M McElrath

J Med Virol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis